Navigation Links
OneOme Receives Laboratory Clinical Certification from Five States

Twin Cities-based pharmacogenomics company OneOme announced today that it has earned laboratory certification in California, Florida, Maryland, Pennsylvania, and Rhode Island. These certifications affirm OneOme’s commitment to exceeding the specific clinical laboratory testing and quality standards required by these five states. OneOme will immediately begin accepting orders from these states for its RightMed® pharmacogenomic test, which analyzes a patient’s genetic profile to determine whether certain medications might be effective for that patient.

“Earning these certifications is a significant step toward our goal of making prescriptions personal for patients around the world,” said Paul Owen, CEO of OneOme. “OneOme is committed to delivering the highest quality pharmacogenomic services to healthcare providers and patients, and earning these certifications demonstrates we are achieving this goal.”

To receive the certifications, OneOme met each state’s rigorous requirements, including:

  •     Completing all the required documentation for the state.
  •     Providing evidence of compliance with CAP, CLIA, and applicable state-specific standards.
  •     Providing assay validation information.

With these certifications in place, OneOme is now able to offer its testing services in 49 states to date. OneOme will seek to obtain the remaining state laboratory certification from New York in 2017.

The RightMed test is a cost-effective, comprehensive, and clinically actionable pharmacogenomic test covering 22 genes, provided as a part of routine clinical care. The test, clinical report, and interactive online tools can help healthcare providers make timely, evidence-based personalized prescription treatment decisions for more than 340 medications. In addition to the RightMed test, OneOme has also developed a platform for clients to generate the interpretive drug report using genotype or sequence data obtained elsewhere.

Studies show about half of the four billion prescriptions issued each year do not work as intended, and adverse drug reactions are the fourth-leading cause of death in the U.S. Genetic factors have been shown to account for up to 95 percent of drug response variability, and the RightMed test can help to identify, based on genetics, which prescriptions may have a more favorable outcome on an individual patient basis. OneOme began offering its RightMed pharmacogenomic test in July 2016.

The RightMed test, which costs $249, is ordered by providers through a HIPAA-compliant portal at, where results are made available and retained. Results are tested at OneOme’s new CAP-accredited clinical laboratory in Minneapolis.

Available worldwide, RightMed is currently available to more than 500,000 patients at Centra Health in the Centra Medical Group Stroobants Cardiovascular Center; in use by Mayo Clinic Center for Individualized Medicine (CIM); in Canada is available through OneOme’s partnership with Medcan, Canada’s largest executive health clinic and a global leader in assessing clients’ overall well-being; and in Puerto Rico, Cuba, and Dominican Republic through a partnership with High Profile Laboratory in Guaynabo, Puerto Rico.

The OneOme platform was co-developed and exclusively licensed from Mayo Clinic to bring pharmacogenomics into routine clinical care. OneOme is a privately held company backed by early-stage venture firm Invenshure, LLC, and Mayo Clinic. To learn more about OneOme, visit


Editor’s Note: Mayo Clinic has financial interest in the technology referenced in this news release. The revenue that Mayo Clinic will receive is used to support its not-for-profit mission in patient care, education and research.

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related medicine news :

1. Career Step COO Receives Military-Friendly Employer Award
2. Aloria Health Receives Joint Commission Accreditation and Residential Licensing
3. Lacto-Freedom Probiotic, a Long Lasting Solution for People Who Have Difficulty Digesting Lactose, Receives Outstanding 5-Star Reviews on
4. Quality Insights Receives Award for Healthcare Quality Improvement Work at Centers for Medicare & Medicaid Services Quality Conference
5. Statlife Receives FDA Approval for DenSeeMammo™
6. The Florida Hospital Tampa Wound Healing Institute Receives Accreditation with Distinction from the Undersea and Hyperbaric Medical Society
7. Florida Teen Receives New Heart For His Birthday And Goes Home For The Holidays
8. Angioma Alliance Receives $50,000 Award from the Julian Grace Foundation to Create Patient Engagement Program in New Mexico
9. GrassrootsHealth Receives Humanitarian Award from the American College of Nutrition
10. California Firefighter Receives $10,000 Thank You From California Casualty
11. Higgins Receives ASDS Outstanding Service Award
Post Your Comments:
(Date:6/18/2019)... SEATTLE (PRWEB) , ... June 18, 2019 , ... ... company developing non-invasive treatments for cancers and other serious diseases, announced it has ... the EMulate Therapeutics application for Humanitarian Device Exemption (HDE) for the Hælo Pediatric ...
(Date:6/18/2019)... ... June 18, 2019 , ... Intalere, ... announced Steve Einig has joined the organization in the newly created role of ... around market engagement, marketing, strategic events and brand management. , “Steve brings a ...
(Date:6/16/2019)... ... June 16, 2019 , ... ... Holdings executives focusing on scientific research for the advancement of medical marijuana-based pharmaceuticals in ... your local listings for more information. , With two investigational new drug applications ...
(Date:6/13/2019)... ... ... Endometriosis is a painful, inflammatory disease that occurs when tissue grows outside of the uterus. ... Heavy bleeding , Irregular menstruation , Severe cramps , ... latest and newest treatment protocols in dealing with the symptoms of endometriosis. In the past, ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... In Partnership ... free dental services for low-income, underinsured individuals at its Mesquite, TX office on July ... x-rays, fillings, cleanings and extractions . For more information, please visit ...
Breaking Medicine News(10 mins):
(Date:6/16/2019)... United Kingdom (PRWEB) , ... June 15, 2019 ... ... , has just published results of a clinical study on its new ... the company used different nutraceutical capsule and chocolate formulations, which were based on ...
(Date:6/14/2019)... , ... June 14, 2019 ... ... SIMPLY, a forecasting and analytics platform that helps Life Sciences Manufacturers accurately ... problems for Life Sciences business leaders: accurate, automated forecasting of rebates and ...
(Date:6/13/2019)... ... 2019 , ... Alliance Cost Containment, LLC (ACC) secured $5.8M in ... The $5.8M in savings is in addition to $17.6M saved over the course of ... acquisition in Q4 2019, the client increased their Fortune 500 status in the healthcare ...
Breaking Medicine Technology: